Research programme: anticancer therapies - Chong Kun Dang
Alternative Names: 3,5-dimethoxy-4-hydroxyethoxycinnamoyl fumagillol; 4-hydroxyethoxycinnamoyl fumagillol; CKD-731Latest Information Update: 13 May 2010
At a glance
- Originator Chong Kun Dang
- Class Esters
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer